These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21766712)

  • 1. [Surgical treatment for metastatic lung cancer treated with bevacizumab].
    Shirato T; Aoki T; Yazawa M
    Kyobu Geka; 2011 Jul; 64(7):579-81. PubMed ID: 21766712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab.
    Scappaticci FA; Fehrenbacher L; Cartwright T; Hainsworth JD; Heim W; Berlin J; Kabbinavar F; Novotny W; Sarkar S; Hurwitz H
    J Surg Oncol; 2005 Sep; 91(3):173-80. PubMed ID: 16118771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic management of colonic perforation owing to angiogenesis inhibitors.
    Ezzedine S; Bege T; Berdah S; Vitton V; Grimaud JC; Barthet M
    Surg Laparosc Endosc Percutan Tech; 2010 Dec; 20(6):e230-2. PubMed ID: 21150409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Spontaneous," delayed colon and rectal anastomotic complications associated with bevacizumab therapy.
    August DA; Serrano D; Poplin E
    J Surg Oncol; 2008 Feb; 97(2):180-5. PubMed ID: 18095268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab.
    Spigel DR; Hainsworth JD; Yardley DA; Raefsky E; Patton J; Peacock N; Farley C; Burris HA; Greco FA
    J Clin Oncol; 2010 Jan; 28(1):43-8. PubMed ID: 19901100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Flap of the musculus latissimus dorsi to prevent alveolar air leakage from sectional plane of the lung after resection of metastatic pulmonary and chest wall tumor].
    Nishiyama N; Nakatani S; Inoue K; Iwasa R; Katoh T; Kinoshita H
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Nov; 44(11):2076-81. PubMed ID: 8958727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of metachronous gastrointestinal perforation of a patient with metastatic rectal cancer during treatment with bevacizumab-based chemotherapy].
    Sadatomo A; Koinuma K; Miki A; Horie H; Yasuda Y
    Gan To Kagaku Ryoho; 2013 Jul; 40(7):943-5. PubMed ID: 23863742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and tolerance of bevacizumab in non-small cell lung cancer: preliminary report].
    Mazières J; Dansin E
    Rev Pneumol Clin; 2008 Aug; 64(4):166-72. PubMed ID: 19019283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies.
    Shih T; Lindley C
    Clin Ther; 2006 Nov; 28(11):1779-802. PubMed ID: 17212999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wound complications after bevacizumab treatment in patients operated on for ovarian cancer.
    Koskas M; Chereau E; Ballester M; Selle F; Rouzier R; Daraï E
    Anticancer Res; 2010 Nov; 30(11):4743-7. PubMed ID: 21115934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic rectal cancer responding to third-line therapy employing bevacizumab after failure of oxaliplatin and irinotecan: case report.
    Shitara K; Munakata M; Muto O; Sakata Y
    Jpn J Clin Oncol; 2008 Jul; 38(7):493-6. PubMed ID: 18567598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bowel perforation from bevacizumab for the treatment of metastatic colon cancer: incidence, etiology, and management.
    Heinzerling JH; Huerta S
    Curr Surg; 2006; 63(5):334-7. PubMed ID: 16971205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bevacizumab in the treatment of advanced, non-squamous non-small cell lung cancer: an evidence-based approach.
    Tassinari D; Sartori S; Papi M; Drudi F; Castellani C; Carloni F; Tombesi P; Lazzari-Agli L
    Oncology; 2011; 80(5-6):350-8. PubMed ID: 21791945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complications of chemotherapy in combination with bevacizumab for treating metastatic colorectal cancer].
    Manikhas GM; Korolenko VO; Al'-Nekhmi AA; Antimonik NIu
    Vopr Onkol; 2010; 56(5):613-6. PubMed ID: 21137245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reversible posterior leukoencephalopathy syndrome associated to bevacizumab].
    Ortiz-Lopez EM; Gonzalez-Nieto JA; Rojas-Marcos I; Blanco-Ollero A
    Rev Neurol; 2010 Jul; 51(2):117-8. PubMed ID: 20602317
    [No Abstract]   [Full Text] [Related]  

  • 16. Tracheoesophageal fistula associated with bevacizumab 21 months after completion of radiation therapy.
    Gore E; Currey A; Choong N
    J Thorac Oncol; 2009 Dec; 4(12):1590-1. PubMed ID: 20009916
    [No Abstract]   [Full Text] [Related]  

  • 17. Pulmonary toxicity after bevacizumab and concurrent thoracic radiotherapy observed in a phase I study for inoperable stage III non-small-cell lung cancer.
    Lind JS; Senan S; Smit EF
    J Clin Oncol; 2012 Mar; 30(8):e104-8. PubMed ID: 22331948
    [No Abstract]   [Full Text] [Related]  

  • 18. [Surgical management of bevacizumab-associated peritonitis due to perforation].
    Kube R; Meyer F; Bien N; Schmidt C; Mroczkowski P; Dalicho S; Lippert H
    Zentralbl Chir; 2009 Sep; 134(5):462-7. PubMed ID: 19757347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diaphragmatic rupture, a new complication of Bevacizumab.
    Lacaze L; Scotté M
    Eur J Surg Oncol; 2012 Nov; 38(11):1079-81. PubMed ID: 22818843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bevacizumab-related surgical site complication despite primary tumor resection in colorectal cancer patients.
    Bège T; Lelong B; Viret F; Turrini O; Guiramand J; Topart D; Moureau-Zabotto L; Giovannini M; Gonçalves A; Delpero JR
    Ann Surg Oncol; 2009 Apr; 16(4):856-60. PubMed ID: 19156464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.